Headache

"Headache" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Descriptor ID	D006261
MeSH Number(s)	C23.888.592.612.441
Concept/Terms	Headache Headache Headaches Head Pain Head Pains Pain, Head Pains, Head Cephalodynia Cephalodynias Cranial Pain Cranial Pains Pain, Cranial Pains, Cranial Cephalalgia Cephalalgias Cephalgia Cephalgias Generalized Headache Generalized Headache Generalized Headaches Headache, Generalized Headaches, Generalized Ocular Headache Ocular Headache Headache, Ocular Headaches, Ocular Ocular Headaches Orthostatic Headache Orthostatic Headache Headache, Orthostatic Headaches, Orthostatic Orthostatic Headaches Vertex Headache Vertex Headache Headache, Vertex Headaches, Vertex Vertex Headaches Retro-Ocular Headache Retro-Ocular Headache Headache, Retro-Ocular Headaches, Retro-Ocular Retro Ocular Headache Retro-Ocular Headaches Sharp Headache Sharp Headache Headache, Sharp Headaches, Sharp Sharp Headaches Throbbing Headache Throbbing Headache Headache, Throbbing Headaches, Throbbing Throbbing Headaches Unilateral Headache Unilateral Headache Headache, Unilateral Headaches, Unilateral Unilateral Headaches Hemicrania Bilateral Headache Bilateral Headache Bilateral Headaches Headache, Bilateral Headaches, Bilateral Periorbital Headache Periorbital Headache Headache, Periorbital Headaches, Periorbital Periorbital Headaches

Below are MeSH descriptors whose meaning is more general than "Headache".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Signs and Symptoms [C23.888]
Neurologic Manifestations [C23.888.592]
Pain [C23.888.592.612]
Headache [C23.888.592.612.441]

Below are MeSH descriptors whose meaning is related to "Headache".

Below are MeSH descriptors whose meaning is more specific than "Headache".

Headache
Slit Ventricle Syndrome

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Headache" by people in this website by year, and whether "Headache" was a major or minor topic of these publications.

Bar chart showing 86 publications over 28 distinct years, with a maximum of 6 publications in 2007 and 2019 and 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1998	0	3	3
1999	1	0	1
2000	1	0	1
2001	2	1	3
2002	1	2	3
2003	1	1	2
2004	2	2	4
2005	0	3	3
2006	0	2	2
2007	4	2	6
2008	0	2	2
2009	4	1	5
2010	3	2	5
2011	1	1	2
2012	4	1	5
2013	2	2	4
2014	2	1	3
2015	3	0	3
2016	2	0	2
2017	0	1	1
2018	0	2	2
2019	5	1	6
2020	2	1	3
2021	1	2	3
2022	1	2	3
2023	0	6	6
2024	1	1	2

Below are the most recent publications written about "Headache" by people in Profiles.

Marmura MJ. Headaches due to Nasal and Paranasal Sinus Disease. Neurol Clin. 2024 May; 42(2S):e1-e13.

View in: PubMed
Nahas SJ. Cranial Neuralgias. Continuum (Minneap Minn). 2024 04 01; 30(2):473-487.

View in: PubMed
Szperka CL, Witzman S, Ostapenko S, Farrar JT, Hsu JY, Malavolta CP, Bunney JD, Bange EM, Patterson Gentile C, Velasquez G, Marquez de Prado B, Cosico M, Lee M, Pojomovsky McDonnell P, Prelack MS, Chadehumbe MA, Stephenson DJ, Kichula EA, Tomaine SC, Hershey AD. Patient headache questionnaires can improve headache diagnosis and treatment in children. Headache. 2023 Nov-Dec; 63(10):1359-1371.

View in: PubMed
Lipton RB, Buse DC, Nahas SJ, Tietjen GE, Martin VT, L?f E, Brevig T, Cady R, Diener HC. Risk factors for migraine disease progression: a narrative review for a patient-centered approach. J Neurol. 2023 Dec; 270(12):5692-5710.

View in: PubMed
Azizoddin DR, Cohn AM, Ulahannan SV, Henson CE, Alexander AC, Moore KN, Holman LL, Boozary LK, Sifat MS, Kendzor DE. Cannabis use among adults undergoing cancer treatment. Cancer. 2023 11 01; 129(21):3498-3508.

View in: PubMed
Yuan H, Natekar A, Park J, Lauritsen CG, Viscusi ER, Marmura MJ. Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis. Reg Anesth Pain Med. 2023 12; 48(12):581-587.

View in: PubMed
Utukuri PS, Shih RY, Ajam AA, Callahan KE, Chen D, Dunkle JW, Hunt CH, Ivanidze J, Ledbetter LN, Lee RK, Malu O, Pannell JS, Pollock JM, Potrebic SX, Setzen M, Shih RD, Soares BP, Staudt MD, Wang LL, Burns J. ACR Appropriateness Criteria? Headache: 2022 Update. J Am Coll Radiol. 2023 05; 20(5S):S70-S93.

View in: PubMed
Starling AJ, Cowan RP, Buse DC, Diener HC, Marmura MJ, Hirman J, Brevig T, Cady R. Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial. Headache. 2023 02; 63(2):264-274.

View in: PubMed
Rethi S, Kairam N, Amato CS, Allegra JR, Eskin B. Six Diagnoses of Separation: Impact of COVID-19 on Pediatric Emergency Department Visits: A Multicenter Study. J Emerg Med. 2022 12; 63(6):723-728.

View in: PubMed
Cowan RP, Marmura MJ, Diener HC, Starling AJ, Schim J, Hirman J, Brevig T, Cady R. Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. J Headache Pain. 2022 Sep 06; 23(1):115.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement